Sinovac Biotech, Ltd (SVA) Posts Q1 Loss of 10c/Share

Article Stock Quotes (1) Comments (0)

Sinovac Biotech, Ltd (NASDAQ: SVA) reported Q1 EPS of ($0.10), $0.03 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $6 million versus the consensus estimate of $7.3 million.

For earnings history and earnings-related data on Sinovac Biotech, Ltd (SVA) click here.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• Jabil Circuit (JBL) Tops Q3 EPS by 2c; Issues Light Q4 Outlook; Will Realign Global Ops
• Actuant Corp. (ATU) Tops Q3 EPS by 3c; Trims FY13 Outlook, Guides FY14
• ChinaEdu Corp. (CEDU) Tops Q1 EPS by 2c

Create E-mail Alert Related Categories

Earnings

Related Entities

Earnings

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?